An open-label, phase I, multi-centre study to evaluate the pharmacokinetic, safety and tolerability profile of oral isavuconazonium sulfate in paediatric patients

An open-label, phase I, multi-centre study to evaluate the pharmacokinetic, safety and tolerability profile of oral isavuconazonium sulfate in paediatric patientsConference abstracts

Source: The Aspergillus Website - updates - June 24, 2020 Category: Respiratory Medicine Authors: MeganB Source Type: news